A book about the mystery of Lyme disease enters the contentious debate about its treatment

A book about the mystery of Lyme disease enters the contentious debate about its treatment

"In a warning letter posted online Monday, FDA regulators say that the Silicon Valley firm has not shown that its tests are safe or effective despite "more than 14 face-to-face and teleconference meetings" and "hundreds of e-mail exchanges." The agency orders 23andMe to stop marketing its test immediately, warning that erroneous results could cause customers to seek unnecessary or ineffective medical care."

http://www.silive.com/healthfit/index.ssf/2013/11/author_delves_into_mystery_of_lyme_disease.html

http://www.silive.com/healthfit/index.ssf/2013/11/author_delves_into_mystery_of_lyme_disease.html